Conferences - Results from #9860

Viewing 9861-9880 of 11775 articles

SIU Congress 2016: Bladder cancer: Frailty as a predictor of complications in older patients undergoing radical cystectomy - Session Highlights

SIU Congress 2016: Reclassification in patients candidates for focal therapy: correlation between transrectal biopsy and histology of the lesions observed in mpMRI on radical prostatectomy specimens. - Session Highlights

SIU Congress 2016: Prostate cancer: Prospective study on the correlation between MRI and pathology of radical prostatectomy specimens - Session Highlights

SIU Congress 2016: Bladder cancer: Radical cystectomy in the elderly- is this a safe treatment option? - Session Highlights

SIU Congress 2016: Bladder cancer: Underutilization of radical cystectomy among elderly patients diagnosed with clinical stage T2 muscle-invasive bladder cancer - Session Highlights

SIU Congress 2016: Challenging cases in bladder cancer: High grade T1 bladder cancer: BCG immunotherapy and urine biomarkers of response - Session Highlights

SIU Congress 2016: Is there a good risk muscle invasive bladder cancer? Neoadjuvant chemotherapy for all vs. for high risk only - Session Highlights

SIU Congress 2016: Is there a good risk muscle invasive bladder cancer? Risk factors associated with understaging - Session Highlights

SIU Congress 2016: Is there a good risk muscle invasive bladder cancer? Cross sectional and functional imaging with PET for staging - Session Highlights

SIU Congress 2016: Challenging cases in bladder cancer: High grade T1 bladder cancer: New promising alternatives for patients who fail BCG immunotherapy - Session Highlights

SIU Congress 2016: New therapies and diagnoses in bladder cancer: changing landscape of systemic therapy - Session Highlights

SIU Congress 2016: New therapies and diagnoses in bladder cancer: Emerging strategies in treatment of BCG unresponsive NMIBC - Session Highlights

SIU Congress 2016: New therapies and diagnoses in bladder cancer: Optimal use of novel biomarkers and detection strategies for bladder cancer - Session Highlights

SIU Congress 2016: : Focal therapy for prostate cancer EXPERT REVIEW - Session Highlights

SIU Congress 2016: Shifting Sands: Testicular cancer: Indication for organ-sparing surgery in testicular lesions - Session Highlights

SIU Congress 2016: Shifting Sands: Testicular Cancer: High dose chemotherapy necessary for intermediate prognosis NSGCT? - Session Highlights

SIU Congress 2016: Shifting Sands: Testicular Cancer: Revival of surgery in stage I NSGCT - Session Highlights

SIU Congress 2016: Debate: T2 and T3a bladder cancer: neoadjuvant chemotherapy should be standard - Session Highlights

SIU Congress 2016: Using pathway analysis and metabolic signature to predict survival in MIBC - Session Highlights

SIU Congress 2016: Unmet needs in upper tract TCC - Session Highlights

489
490
491
492
493
494
495
496
497
498